New ORISE Fellowship Opportunities
The Food and Drug Administration and the National Institute of Environmental Health Sciences National Toxicology Program (NTP) have partnered to offer Oak Ridge Institute for Science and Education (ORISE) fellowship positions focused on cardiovascular drug safety screening. The initiative’s goal is to develop a novel framework to model cardiovascular hazards and understand the underlying pathways. The fellowship position will be located at the NTP in Research Triangle Park, North Carolina, USA.
Read more or apply online
here
.
|
|
On September 21, HESI’s Executive Director, Syril Pettit, attended the Biden Cancer Summit on behalf of the
HESI THRIVE
Initiative.
THRIVE is
one of only fifty programs nationwide
recognized by the Biden Cancer Initiative
toward their goal of rapidly advancing cancer cures and improving patient outcomes.
HESI THRIVE
, now in its second funding cycle, is a grant program that provides seed funding for research to better understand and reduce cancer treatment-related adverse effects that can impact patient quality of life. THRIVE helps to enhance the lifetime benefit of existing therapies by better predicting, preventing, or reducing unintended adverse effects associated with therapy.
|
|
Special thanks to HESI THRIVE’s 2018 supporters: HESI, Amgen, and the National Patient Advocate Foundation. If you’d like to join as a supporter for this amazing program – please contact us at
research@hesithrive.org
.
Grant proposals are due
19 October 2018, so act now!
The Advisory Board will invite a limited number of initial submissions to submit a full proposal, with the next grant award period to launch in early 2019.
Read the full press release
here
, and visit the THRIVE website
here
.
|
|
Emerging Issues 2019: Call for Proposals
|
|
HESI is seeking your suggestions for new scientific projects (human or environmental health) for consideration as an emerging issue in 2019. Proposals will be reviewed in early 2019, and one or more will be selected to form a new scientific collaborative program within HESI. Although this is not a grant, the selected program will receive support from HESI for scientific program design, coordination, and staffing.
Learn more about the HESI Emerging Issues Process on our
website
or download the proposal form
here
. The deadline to submit proposals is
14 December 2018
. Don’t miss out!
|
|
New Staff
Please join us in welcoming HESI’s newest staff member, Maddy Barnes! Maddy is our Member Relations & Communications Manager and comes to us with her BA from the University of Michigan. Before joining HESI, Maddy worked as the Marketing & Communications Manager for Make-A-Wish
®
Mid-Atlantic and has past experience working in healthcare communications and public relations.
|
|
Recent Publication
Blinova K, Dang Q, Millard D, Smith G, Pierson J, Liang G, Brock M, Lu HR, Kraushaar U, Zeng H, Shi H, Zhang X, Sawada K, Osada T, Kanda Y, Sekino Y, Pang L, Feaster TK, Kettenhofen R, Stockbridge N, Strauss DG, and Gintant G (2018) International multisite study of human induced pluripotent stem cell derived cardiomyocytes for drug proarrhythmic potential assessment.
Cell Reports.
24(13):3582–3592.
Read More
|
|
From the Executive Director
|
|
What an incredible honor and thrill to attend the inaugural Biden Cancer Summit last month. Not surprisingly for an event hosted by a former Vice-President - it was filled with the nation’s leading cancer researchers and clinicians, directors of patient advocacy organizations, tech-company CEOs, and therapy developers. But it was not their presence that left the greatest impact on me. Rather, it was the voices of the patients, the parents, and the families whose lives have been forever impacted by cancer. These voices resonate not only because they are honest and raw – but because we have all heard or spoken with that voice in our own lives as well. Initiatives like the Biden Cancer Summit shine a light on the breadth of challenges and opportunities ahead – and the millions of people seeking this better future. Programs like HESI THRIVE and innovative research partnerships within HESI’s Cardiac and Immunotoxicology Committees are also critical steps forward. To learn more about how to join or support us in these efforts, please contact me at
research@hesithrive.org
.
|
|
Syril D. Pettit
HESI Executive Director
|
|
Health and Environmental Sciences Institute (HESI)
740 Fifteenth Street, NW
6th Floor
Washington, DC 20005-1743
| 202.659.3306 | 202.659.3859| HESI@hesiglobal.org| www.hesiglobal.org
|
|
|
|
|
|
|
